Find uplifting stories about heroes, innovations, and solutions
6052 results for "psoriasis treatment"
Scientists at Newcastle and Queen Mary universities have identified genetic markers that could transform psoriasis treatment into truly personalized care. The breakthrough analyzed over 700 patient samples using AI to decode which treatments work best for individual patients.
Scientists have developed a groundbreaking psoriasis treatment that only activates when exposed to light, eliminating dangerous side effects that have plagued previous therapies. The innovation could help millions access affordable, targeted treatment for this painful skin condition.
Johnson & Johnson just won approval for the first daily pill that matches the power of injectable psoriasis treatments. The breakthrough could help millions who avoid shots and reshape how we treat this painful skin condition.
A once-daily pill called zasocitinib cleared severe psoriasis in 70% of patients within 16 weeks, matching results previously only seen with injections. The breakthrough could transform treatment for millions who've had to choose between convenience and effectiveness.
A new once-daily pill just became the first FDA-approved oral peptide treatment for moderate-to-severe plaque psoriasis, offering hope to millions who've struggled with painful skin lesions. The breakthrough medication cleared or nearly cleared skin in 70% of patients during clinical trials.
A breakthrough treatment for plaque psoriasis cleared skin completely in 63% of patients during mid-stage trials, matching top medications while requiring just one shot per year. Oruka Therapeutics' ORKA-001 could transform life for millions living with the painful autoimmune condition.
A new injectable treatment for psoriasis helped nearly two-thirds of patients achieve completely clear skin in clinical trials. Even better, patients may only need one shot per year instead of monthly injections.
A new once-daily pill just won FDA approval after helping 7 out of 10 people with moderate to severe psoriasis achieve clear or nearly clear skin in clinical trials. The treatment offers hope to more than 8 million Americans living with the painful skin condition.
Scientists discovered that keratin 16 acts as a natural "brake" on skin inflammation, explaining why mutations cause painful conditions like psoriasis and eczema. This breakthrough could lead to targeted treatments for millions suffering from inflammatory skin diseases.
After 20 years of research, scientists are now seeing real evidence that a permanent cure for psoriasis could arrive within the next 10 years. New medications are keeping patients clear even after treatment stops.
Researchers discovered why some psoriasis patients develop painful joint inflammation and identified a way to catch it before damage begins. The breakthrough could help protect up to 30% of psoriasis patients from permanent joint damage.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Showing 20 of 6052